CEL-SCI CORPORATION Payments for Repurchase of Redeemable Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- CEL-SCI CORPORATION payments for repurchase of redeemable preferred stock for fiscal 2013 was $0.00.
- CEL-SCI CORPORATION payments for repurchase of redeemable preferred stock for fiscal 2012 was $0.00, a 100.00% decline from fiscal 2011.
- CEL-SCI CORPORATION payments for repurchase of redeemable preferred stock for fiscal 2011 was $4.05M.
| Period end | Payments for Repurchase of Redeemable Preferred Stock 3 month | Payments for Repurchase of Redeemable Preferred Stock 12 month |
|---|---|---|
| 2013-09-30 | $0.00 10-K · filed 2013-12-27 | |
| 2012-09-30 | $0.00 10-K · filed 2013-12-27 | |
| 2011-09-30 | $4.05M 10-K · filed 2013-12-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |